Explore independent coverage from SABCS 2026, where the global breast cancer community will gather to examine the research, biomarkers, and treatment strategies shaping patient care.
The San Antonio Breast Cancer Symposium brings together more than 11,000 physicians, researchers, clinicians, and patient advocates from over 100 countries. Its scientific program spans the full continuum of breast cancer research—from experimental biology, prevention, and early detection to translational science, clinical trials, and evolving approaches to treatment.
Formal lectures, oral and poster presentations, forums, and case discussions give healthcare professionals an opportunity to evaluate new evidence across early-stage, locally advanced, and metastatic disease. The meeting also connects laboratory discoveries with practical questions about diagnosis, biomarker testing, treatment selection, sequencing, safety, and survivorship.
Conference Insider will follow clinically relevant developments before, during, and after the meeting. Coverage will focus on concise news updates, expert context, and practical takeaways that help healthcare professionals understand how emerging SABCS data may fit into the broader breast cancer landscape.
What to expect from our coverage
- Timely reports on notable clinical and translational research
- Context around biomarkers, resistance mechanisms, and treatment sequencing
- Coverage across early-stage and advanced breast cancer
- Clear summaries designed for healthcare professionals